WiseApp for Spanish Speakers Living with HIV

Description

This study aims to conduct a 12-month randomized controlled trial to adapt the mobile app, WiseApp, and a smart pill dispenser for Spanish-speaking people living with HIV (PLWH) in the New York City (NYC) area and La Romana, Dominican Republic (DR). The study will assess the efficacy and sustainability of WiseApp as well as identify barriers with its widespread use among Spanish speakers. With disproportionately high rates of HIV in the New York City area and the Dominican Republic, this project seeks to identify distinct contextual factors related to Spanish speaking people living with HIV and increase the likelihood of engagement with technology and improvements in clinical outcomes.

Conditions

HIV Infections, Acquired Immune Deficiency Syndrome, Sexually Transmitted Diseases, Viral

Talk to us

Study Overview

On this page

Study Details

Study overview

This study aims to conduct a 12-month randomized controlled trial to adapt the mobile app, WiseApp, and a smart pill dispenser for Spanish-speaking people living with HIV (PLWH) in the New York City (NYC) area and La Romana, Dominican Republic (DR). The study will assess the efficacy and sustainability of WiseApp as well as identify barriers with its widespread use among Spanish speakers. With disproportionately high rates of HIV in the New York City area and the Dominican Republic, this project seeks to identify distinct contextual factors related to Spanish speaking people living with HIV and increase the likelihood of engagement with technology and improvements in clinical outcomes.

WiseApp for Spanish-Speaking Latino Persons Living with HIV (PLWH) in the United States (US) and the Dominican Republic (DR)

WiseApp for Spanish Speakers Living with HIV

Condition
HIV Infections
Intervention / Treatment

-

Contacts and Locations

New York

Columbia University Irving Medical Center, New York, New York, United States, 10032

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Able to speak, read, and write in Spanish;
  • * Aged ≥18 years;
  • * Willing to participate in any assigned arm of the intervention;
  • * Have an HIV-1 RNA level \>50 copies/mL;
  • * Own a smartphone (DR participants who are eligible but without access to a smartphone will get one as part of the study at the time of enrollment); and
  • * Ability and willingness to provide informed consent for study participation and consent for access to medical records.
  • * Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment;
  • * Terminal illness with life expectancy \<6 months;
  • * Planning to move out of the area in the next 12 months;
  • * A cognitive state minimum score measured by the Mini-Mental State Examination (MMSE) to ensure participants are oriented to time and place.
  • * Spouses/partners may not enroll in this study. The study will be limited to only 1 person from the same family/domestic household.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Columbia University,

Rebecca Schnall, PhD, MPH, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

2027-01